Thymic involution constitutes a hallmark of an aging immune system. The thymus is comprised of thymic epithelial cells (TECs), fibroblasts and blood-borne stromal cells. Adoptive transfers of young and old hematopoietic stem cells into young vs old recipients has led to the conclusion that impaired thymopoiesis in the aged is largely the consequence of an aged thymic microenvironment. TEC differentiation, proliferation, and survival are controlled by cell intrinsic and extrinsic factors. Although much work has been focused on thymus development during embryogenesis, comparatively little is known about the mechanisms responsible for thymic involution. This especially pertains to TECs, which we hypothesize are the major impediment to thymopoiesis during aging. We now propose to fill this critical gap.
Our specific aims are:
Aim 1 : To determine the key transcription factors &signaling pathways in TECs affected by aging.
In aim 1 A, we will interrogate physiological characteristics of aged vs young TEC subsets.
In aim 1 B, we hypothesize that key cell surface receptor and intracellular transcriptional pathways that regulate thymic development will be important for TEC maintenance and regeneration after genotoxic stress in aged mice.
In aim 1 C, we hypothesize that transcriptional regulation by micro-RNAs is an important component of TEC aging. Studies of loss-of-function in TECs alone will be performed in aims 1B and 1C.
Aim 2 : To test the hypothesis that genetic models of perturbations of the aging process will provide key insights as to the mechanisms responsible for TEC aging. We will identify common features affecting TECs between chronologically aged mice and those with premature aging and distinguishing features in a model of delayed thymic aging. As indicated, drugs that stimulate TECs as probes for assessing residual TEC function in aging.
Our goal is to understand the causes of aged-related thymic involution and it subsequent immune deficiency. These studies, which include therapeutic interventions that are exportable into the clinic, offer the possibility of diminishing age-related complications of a poor immune system response.
|Bouchlaka, Myriam N; Sckisel, Gail D; Chen, Mingyi et al. (2013) Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J Exp Med 210:2223-37|